Smoking Linked to Cognitive Decline in Children: Study

Aug.31.2022
Smoking Linked to Cognitive Decline in Children: Study
Smoking linked to poor cognitive performance and brain volume reduction in children, per a 2-year study on 1000+ children in Nebraska, US.

A study conducted in the state of Nebraska, United States revealed that smoking is associated with poor cognitive performance and reduced brain volume among more than 1,000 children aged 9 to 10 years old who were followed up for two years. The study found that the effects of smoking could have a lasting impact.


Among those investigated, 116 children reported using tobacco products and were considered to be the earliest group of tobacco users in the study. This group performed poorly on the tests (mean, b = -2.9; SE, 0.6; P <.001), showing lower crystallized cognitive composite scores (b = -2.4; SE, 0.5; P <.001) and total cognitive composite scores (b = -2.9; SE, 0.5; P = .01). In a follow-up study of two years, smokers had lower cortical volumes in the frontal, parietal, and temporal lobes than non-users.


According to a report by Dr. Hongying Daisy Dai, Chief Researcher at the University of Nebraska Medical Center, electronic cigarettes and smokeless tobacco products should not be considered as a substitute to traditional cigarettes for youth to reduce tobacco-related harm. Authorities should implement comprehensive intervention strategies and tobacco control policies to prevent tobacco initiation.


From October 2016 to October 2018, a study titled Adolescent Brain Cognitive Development (ABCD) included 11,729 children from 21 US-based websites. This study followed up with the participants from August 2018 to January 2021. Participants were asked to complete a survey about tobacco use, including e-cigarettes, cigarettes, cigars, smokeless tobacco, hookah, pipes, and nicotine replacement products.


Dai and colleagues utilized a comprehensive combination of cognitive assessment measures, including the National Institutes of Health Toolbox Cognitive Battery, morphometric analysis, and structural MRI, to evaluate differences between users and non-users. In terms of race and ethnicity, 2.1% of the sample were Asian; 20.3% were Hispanic/Latino; 14.9% were non-Hispanic Black; and 52.1% were non-Hispanic White. Just over a quarter (27.3%) of the sample had parents who were college graduates, and 13.7% had parents with an annual income less than $25,000.


During a two-year follow-up period, the scores of first-time tobacco users in oral recognition (b=-2.1; SE, 0.5; P<.001), picture sequencing memory (b=-3.0; SE, 0.7; P<.001), and crystallized cognitive composite scores (b=-2.7; SE, 0.8; P=.005) remained lower than non-users. In SMRI analysis, former smokers exhibited significantly decreased measurements in the entire brain, including the total cortical surface area in the first wave (b=-5014.8 mm3; SE, 7043.9; P=.002), total cortical volume in the first wave (b=-174,621.0 mm3; SE, 5857.7; P=.003) and follow-up (b=-21,790.8 mm3; SE, 7043.9; P=.002), and total intracranial volume in the first wave (b=-38,442.8 mm3; SE, 12,057.7; P=.009).


In a related editorial, Dr. Laviolette from the University of Western Ontario wrote, "The findings reported by Dai and colleagues raise many important questions for future clinical and preclinical investigations. It is important to determine the extent to which these pathophysiological findings extend beyond the window of brain maturation prior to adolescence. Furthermore, it is crucial to identify the specific molecular mechanisms and biomarkers underlying these persistent tobacco-induced pathophysiological effects.


He added that the description of potential mechanisms could facilitate similar identification of intervention and reversal strategies for "neurological and psychiatric phenotypes caused by nicotine exposure in children, adolescents, and even prenatal exposure." Additionally, advances in genomic and transcriptomic analysis could better understand the potential genetic factors that could make individuals more susceptible to nicotine products during critical periods of brain development, as well as factors that could increase the risk of serious neurological and cognitive outcomes after exposure to nicotine during the developmental window for some individuals.


Statement: 1. This article's content is based on the compilation of third-party information and is intended solely for industry exchanges and learning purposes. 2. The views expressed in this article do not represent those of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The compilation of this article is for industry exchange and research purposes only. 3. Due to limited compilation skills, the translated article may not fully reflect the original text. Please refer to the original text for accuracy. 4. Regarding any domestic, Hong Kong, Macao, Taiwan, or international statements or positions, 2FIRSTS is fully aligned with the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. Please contact us for removal if there are any infringements.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

KT&G Q1 2026 Financial Results: Revenue at $1.156 Billion, E-Cigarettes to Launch Independent Overseas Expansion
KT&G Q1 2026 Financial Results: Revenue at $1.156 Billion, E-Cigarettes to Launch Independent Overseas Expansion
KT&G reports a 27.6% increase in Q1 operating profit, with traditional and new tobacco sectors driving growth.
May.07 by 2FIRSTS.ai
Australia Quantifies Black Market for First Time, Illicit Nicotine Products Account for About 80% of Consumption
Australia Quantifies Black Market for First Time, Illicit Nicotine Products Account for About 80% of Consumption
The Australian Bureau of Statistics (ABS) has released its first estimate of the illicit nicotine market, finding that about 80% of cigarettes, vapes and other nicotine products consumed in 2025 came from illegal sources, reigniting debate over tobacco taxation and enforcement policies.
Jun.03
 BAT Bangladesh Cigarette Sales Fall 14%, Q1 Profit Drops 34%
BAT Bangladesh Cigarette Sales Fall 14%, Q1 Profit Drops 34%
British American Tobacco Bangladesh reported a 14% year-on-year decline in cigarette sales volume and a 34% drop in first-quarter profit, highlighting mounting pressure from inflation, taxation, and weakening consumer spending in Bangladesh.
News
May.18
Revised Tobacco Business Act to Take Effect in South Korea, Banning Online Sales of Liquid Vapes
Revised Tobacco Business Act to Take Effect in South Korea, Banning Online Sales of Liquid Vapes
South Korea’s Ministry of Health and Welfare will implement a partial revision of the Tobacco Business Act on April 24. The scope will expand from products made with “tobacco leaves” to all products manufactured with natural or synthetic nicotine. Synthetic nicotine liquid e-cigarettes, which had previously been treated as industrial products and were freely sold and advertised online, will from April 24 be subject to the same regulations as ordinary tobacco products.
Apr.23 by 2FIRSTS.ai
Philippine Health Department Pushes Total Vape Ban, With Tobacco-Only Flavor Limit as Alternative
Philippine Health Department Pushes Total Vape Ban, With Tobacco-Only Flavor Limit as Alternative
The Philippine Department of Health said it is pushing for a total ban on vape products. If a full ban is not feasible, DOH officer-in-charge Director Dr. Dominic Maddumba said vape products should at least be limited to plain tobacco flavors to reduce their appeal to minors.
May.06 by 2FIRSTS.ai
FDA Renews Exposure Modification Authorization for IQOS Devices and Three HeatSticks Products
FDA Renews Exposure Modification Authorization for IQOS Devices and Three HeatSticks Products
U.S. Food and Drug Administration renewed modified risk granted orders for five IQOS products from Philip Morris Products S.A., including two IQOS system holders and chargers and three HeatSticks products. Under the renewed orders, the products may continue to be marketed with an exposure modification claim.
Apr.20 by 2FIRSTS.ai